BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers

ABSTRACT: Expression data from patient-derived xenografts of human triple-negative breast cancers

ORGANISM(S): Homo sapiens

PROVIDER: GSE142639 | GEO | 2019/12/28

REPOSITORIES: GEO